Show simple item record

dc.contributor.authorBarnes, S. A.
dc.contributor.authorWijetunge, L. S.
dc.contributor.authorJackson, A. D.
dc.contributor.authorKatsanevaki, D.
dc.contributor.authorOsterweil, E. K.
dc.contributor.authorKomiyama, N. H.
dc.contributor.authorGrant, S. G. N.
dc.contributor.authorNagerl, U. V.
dc.contributor.authorKind, P. C.
dc.contributor.authorWyllie, D. J. A.
dc.contributor.authorBear, Mark
dc.date.accessioned2017-05-12T22:57:55Z
dc.date.available2017-05-12T22:57:55Z
dc.date.issued2015-11
dc.identifier.issn0270-6474
dc.identifier.issn1529-2401
dc.identifier.urihttp://hdl.handle.net/1721.1/109066
dc.description.abstractPrevious studies have hypothesized that diverse genetic causes of intellectual disability (ID) and autism spectrum disorders (ASDs) converge on common cellular pathways. Testing this hypothesis requires detailed phenotypic analyses of animal models with genetic mutations that accurately reflect those seen in the human condition (i.e., have structural validity) and which produce phenotypes that mirror ID/ASDs (i.e., have face validity). We show that SynGAP haploinsufficiency, which causes ID with co-occurring ASD in humans, mimics and occludes the synaptic pathophysiology associated with deletion of the Fmr1 gene. Syngap[superscript +/−] and Fmr1[superscript −/y] mice show increases in basal protein synthesis and metabotropic glutamate receptor (mGluR)-dependent long-term depression that, unlike in their wild-type controls, is independent of new protein synthesis. Basal levels of phosphorylated ERK1/2 are also elevated in Syngap[superscript +/−] hippocampal slices. Super-resolution microscopy reveals that Syngap[superscript +/−] and Fmr1[superscript −/y] mice show nanoscale alterations in dendritic spine morphology that predict an increase in biochemical compartmentalization. Finally, increased basal protein synthesis is rescued by negative regulators of the mGlu subtype 5 receptor and the Ras–ERK1/2 pathway, indicating that therapeutic interventions for fragile X syndrome may benefit patients with SYNGAP1 haploinsufficiency.en_US
dc.language.isoen_US
dc.publisherSociety for Neuroscienceen_US
dc.relation.isversionofhttp://dx.doi.org/10.1523/jneurosci.1087-15.2015en_US
dc.rightsCreative Commons Attributionen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.sourceSociety for Neuroscienceen_US
dc.titleConvergence of Hippocampal Pathophysiology in Syngap[superscript +/-] and Fmr1[superscript -/y] Miceen_US
dc.title.alternativeConvergence of Hippocampal Pathophysiology in Syngap+/- and Fmr1-/y Miceen_US
dc.typeArticleen_US
dc.identifier.citationBarnes, S. A. et al. “Convergence of Hippocampal Pathophysiology in Syngap+/- and Fmr1-/Y Mice.” Journal of Neuroscience 35.45 (2015): 15073–15081.en_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Brain and Cognitive Sciencesen_US
dc.contributor.departmentPicower Institute for Learning and Memoryen_US
dc.contributor.mitauthorBear, Mark
dc.relation.journalJournal of Neuroscienceen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dspace.orderedauthorsBarnes, S. A.; Wijetunge, L. S.; Jackson, A. D.; Katsanevaki, D.; Osterweil, E. K.; Komiyama, N. H.; Grant, S. G. N.; Bear, M. F.; Nagerl, U. V.; Kind, P. C.; Wyllie, D. J. A.en_US
dspace.embargo.termsNen_US
mit.licensePUBLISHER_CCen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record